NCT03815357 - What is the Incidence of an Immune Disorder in Children With Invasive Pneumococcal Disease (IPD)? | Biotech Hunter

Enrollment

380

Participants

Timeline

Start Date

January 31, 2017

Primary Completion Date

June 30, 2021

Study Completion Date

June 30, 2021

Conditions

Invasive Pneumococcal Disease, Recurrent Isolated, 1Invasive Pneumococcal Disease, Recurrent Isolated, 2Invasive Pneumococcal Disease, Protection AgainstPrimary Immunodeficiency

Interventions

OTHER

Referral to Immunology

Screening for primary immunodeficiency including splenic dysfunction

Trial Locations (6)

2031

Sydney Children's Hospital, Sydney

3049

Royal Children's Hospital, Melbourne

Unknown

Adelaide Women's and Children's Hospital, Adelaide

Monash Health, Clayton

Lady Cilento Children's Hospital, Brisbane

Capital and Coast District Health Board, Wellington